They have also been able to discover that the dysfunction in the metabolic peptides responsible for insulin production and blood glucose regulation leads patients to have decreased levels of acetylcholine (ACh), which has been known to be associated with AD, as the plaques developed by the disease damage and break down cells that produce and use ACh. The gene discussed is INS; the disease is Alzheimer disease.